-+ 0.00%
-+ 0.00%
-+ 0.00%

TriSalus Life Sciences Q3 EPS $(0.15) Misses $(0.13) Estimate, Sales $12.900M Miss $14.024M Estimate

Benzinga·11/10/2026 13:11:37
Listen to the news
TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 84.38 percent increase over losses of $(0.96) per share from the same period last year. The company reported quarterly sales of $12.900 million which missed the analyst consensus estimate of $14.024 million by 8.01 percent. This is a 11.53 percent increase over sales of $11.566 million the same period last year.